Altered Adipokine Response in Murine 3T3-F442A Adipocytes Treated with Protease Inhibitors and Nucleoside Reverse Transcriptase Inhibitors
- 1 February 2005
- journal article
- research article
- Published by SAGE Publications in Antiviral Therapy
- Vol. 10 (2) , 207-213
- https://doi.org/10.1177/135965350501000202
Abstract
Background: Abnormal levels of tumour necrosis factor (TNF)-α, interleukin (IL)-6 and adiponectin have been observed in HIV patients with lipodystrophy. However, because these patients have long drug and disease histories, it is unclear which drugs are responsible for these abnormalities. We have therefore investigated the effects of individual antiretrovirals on adipokine expression and adipogenesis using a murine cell line in vitro. Methods: Differentiating murine 3T3-F442A adipocytes were incubated with 20 μM nucleoside reverse transcriptase inhibitors (NRTIs) zidovudine or stavudine, or protease inhibitors (PIs) indinavir, ritonavir, saquinavir or nelfinavir, in the presence and absence of rosiglitazone (10 μM). Adipogenesis was assessed using glycerol-3-phosphate dehydrogenase activity, while expression of TNF-α, IL-6 and adiponectin at protein and mRNA levels was assessed by ELISA and quantitative real-time PCR, respectively. Results: Nelfinavir, ritonavir and saquinavir inhibited adipogenesis and up-regulated the expression of TNF-α and IL-6, but this effect was not seen with indinavir, zidovudine and stavudine. Adiponectin expression was significantly reduced in both NRTI- and PI-treated cells, although the most profound reductions were found with ritonavir and saquinavir. Co-incubation with rosiglitazone led to a partial attenuation of the change in TNF-α, IL-6 and adiponectin secretion. Conclusions: Our data suggest that the PIs nelfinavir, ritonavir and saquinavir have potent effects in inhibiting adipocyte differentiation whilst up-regulating TNF-α and IL-6 mRNA levels and decreasing adiponectin levels. These changes were partially attenuated by rosiglitazone. Taken together, the data show that antiretrovirals have complex effects on adipocyte function, which may be mediated by an altered adipokine response.Keywords
This publication has 39 references indexed in Scilit:
- Troglitazone Antagonizes Tumor Necrosis Factor-α-induced Reprogramming of Adipocyte Gene Expression by Inhibiting the Transcriptional Regulatory Functions of NF-κBJournal of Biological Chemistry, 2003
- Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapyAIDS, 2003
- Regulation of Plasma PAI-1 Concentrations in HAART-Associated Lipodystrophy During Rosiglitazone TherapyArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Tumour necrosis factor-alpha gene -238G/A promoter polymorphism associated with a more rapid onset of lipodystrophyAIDS, 2003
- TNF-α promoter region gene polymorphisms in HIV-positive patients with lipodystrophyAIDS, 2002
- Hormonal Regulation of Adiponectin Gene Expression in 3T3-L1 AdipocytesBiochemical and Biophysical Research Communications, 2002
- Secretion of Adiponectin and Regulation of apM1 Gene Expression in Human Visceral Adipose TissueBiochemical and Biophysical Research Communications, 2001
- Differential Regulation of Adipocytokine mRNAs by Rosiglitazone in db/db MiceBiochemical and Biophysical Research Communications, 2001
- Suppression of Preadipocyte Differentiation and Promotion of Adipocyte Death by HIV Protease InhibitorsJournal of Biological Chemistry, 2000
- cDNA Cloning and Expression of a Novel Adipose Specific Collagen-like Factor, apM1 (AdiposeMost Abundant Gene Transcript 1)Biochemical and Biophysical Research Communications, 1996